ACUTE SIDE EFFECTS OF HYPOFRACTIONATED RADIOTHERAPY (HYPORT) IN LOCALISED PROSTATE CANCER

被引:0
|
作者
Macias Hernandez, V. [1 ]
Garcia-Ruiz, J. [1 ]
Girabent-Farres, M. [2 ]
机构
[1] Capio Hosp Gen Catalunya, Radiat Oncol, Sant Cugat Del Valles, Barcelona, Spain
[2] Univ Int Catalunya, Dept Stat, Sant Cugat Del Valles, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1504
引用
收藏
页码:S478 / S478
页数:1
相关论文
共 50 条
  • [1] Phase II study of hypofractionated radiotherapy (HYPORT) in localised prostate cancer: Report on acute and 18 month late toxicity
    Garcia-Rojo, Dario
    Macias, Victor
    Gonzalez, Jose L.
    Gallardo, Enrique
    Prera, Angel
    Abad, Carlos
    Vicente, Eduardo
    Hannaoui, Naim
    Martos, Raul
    Ropero, Jordi
    Prats, Juan
    JOURNAL OF UROLOGY, 2008, 179 (04): : 397 - 398
  • [2] Phase II study of hypofractionated radiotherapy (hyport) in localised prostate cancer: Report on acute and 18 month late toxicity
    Garcia-Rojo, D.
    Macias, D.
    Gonzalez, D.
    Gallardo, D.
    Martos, D.
    Ropero, D.
    Vicente, D.
    Abad, D.
    Hannaoui, D.
    Prera, D.
    Prats, D.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 117 - 117
  • [3] Weekly ultra-hypofractionated radiotherapy in localised prostate cancer
    Sundahl, Nora
    Brand, Douglas
    Parker, Chris
    Dearnaley, David
    Tree, Alison
    Pathmanathan, Angela
    Suh, Yae-eun
    Van As, Nicholas
    Eeles, Rosalind
    Khoo, Vincent
    Huddart, Robert
    Murray, Julia
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 47
  • [4] Hypofractionated Radiotherapy with Cyberknife for Localised Prostate Cancer: Early Experience
    Tree, A.
    Wells, E.
    Khoo, V.
    van As, N.
    CLINICAL ONCOLOGY, 2013, 25 (04) : E72 - E73
  • [5] Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials
    Macias, Victor
    Biete, Albert
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (07): : 437 - 445
  • [6] Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials
    Víctor Macías
    Albert Biete
    Clinical and Translational Oncology, 2009, 11 : 437 - 445
  • [7] Ultra-hypofractionated radiotherapy in High risk localised prostate cancer
    Colom Pla, Claudia
    Navarro Aznar, Victoria
    Garcia Aguilera, Cristina
    Cerrolaza Pascual, Maria
    Lanuza Carnicer, Alberto
    Galan Garcia, Ana
    Mendez Villamon, Agustina
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2568 - S2569
  • [8] ACUTE AND LATE TOXICITY IN HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN SUPPRESSION AND HYPOFRACTIONATED RADIOTHERAPY (HYPORT) TO THE PROSTATE AND PELVIC NODES
    Faria, Sergio
    Petrucelli, Mariana
    Cury, Fabio
    Duclos, Marie
    Souhami, Luis
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S21 - S21
  • [9] Acute effects after HYPO-fractionated radiotherapy (HYPORT) of intermediate risk prostate cancer
    Widmark, A
    Fransson, P
    Bergström, P
    Löfroth, P
    Zackrisson, B
    Franzen, L
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S408 - S408
  • [10] Acute toxicity of high dose hypofractionated 3D conformal radiotherapy in localised prostate cancer
    Macias Hernandez, V.
    Marcos-Pascua, P.
    Pijls-Johannesma, M.
    Modolell, I.
    Gallardo, J.
    Prats, J.
    Macias, D.
    Pardo, J.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S439 - S440